Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

MEDICC Deplores President Trump’s Rollback on US Opening to Cuba: Unhealthy, Unreasonable, Unwise
  • USA - English


News provided by

Medical Education Cooperation With Cuba

Jun 19, 2017, 20:15 ET

Share this article

Share toX

Share this article

Share toX


Oakland, CA (PRWEB) June 19, 2017 -- The Trump administration’s about-face on Cuba policy threatens the benefits of bilateral health cooperation for Americans, Cubans and people around the world. The June 16th Presidential Memorandum makes passing reference to “ensure engagement” to protect “public health and safety of the United States”. However, the directive’s harsh restrictions on travel, trade and investment risk freezing joint research on disease and bilateral accords to mitigate natural disasters, protect shared ecosystems, counter drug-trafficking and halt new epidemics.

There are no winners in a return to antiquated policies, but yes, the real possibility is that health—our own and globally—becomes just part of the ‘collateral damage’.

Post this

While specifics are yet unclear, the stakes are high. MEDICC Board Vice Chair Arnold Perkins commented: “This policy turnaround is as unwise as it is unhealthy, especially since Cuba has promising treatments for lung and other cancers, and for reducing by 70% risk of amputation for diabetic-foot-ulcer patients, among others. Ordinary Americans and Cubans stand to lose if US companies and universities cannot fully partner with Cuba’s research centers on these and other innovations.”

MEDICC Executive Director Dr. C. William Keck called the policy also unreasonable, contradicting overwhelming support for better relations with Cuba found among Americans (including Republicans), Cuban-Americans and Cubans on the island. “This administration is turning its back on us, and also on lessons from a country whose free health care has produced outcomes similar and sometimes better than our own, with fewer disparities, despite economic hardships due in part to the US embargo,” he said. In this regard, Dr. Keck referred to MEDICC’s Community Partnerships for Health Equity (CPHE) in 12 US cities, where community leaders travel to Cuba to gain insights for improving health and health equity back home.

He also noted that full Cuban scholarships have already permitted over 200 low-income young Americans to study medicine in Havana. As a result of this Cuban investment—estimated at over $20 million—more than 90% of the already-practicing graduates are working in US underserved areas, a "program MEDICC is proud to support”.

By further undermining the Cuban economy, the presidential directive puts at risk the continuation of such scholarships, as well as Cuba’s global health cooperation with developing countries, where its first responders have risked their own lives to save others, whether facing the Ebola outbreak or the aftermath of Haiti’s earthquake.

MEDICC helped open the door to bilateral health collaboration with its 2016 white paper sent to President Obama. A Safer, Healthier Future Through U.S.-Cuba Cooperation contained several recommendations adopted in his ensuing executive orders...including those allowing Cuban cancer-fighting medicines to be tested in the USA.

It is imperative that such collaboration in health and science move ahead, despite obstacles presented by the policy shift: MEDICC is fully committed to this effort. “There are no winners in a return to antiquated policies, but yes, the real possibility is that health—our own and globally—becomes just part of the ‘collateral damage’. History has shown that engaging with Cuba is the only way forward,” stressed Mr. Perkins.

......
Founded in 1997, MEDICC is a nonprofit organization based in Oakland, California that has worked to promote US-Cuba health collaboration and highlight Cuba’s public health contributions to global health equity and universal health. MEDICC facilitates mutual learning opportunities in several ways: its documentary film ¡Salud!; the open-access, MEDLINE-indexed English journal, MEDICC Review, that publishes research by Cuban and other scholars from the Global South whose work addresses health equity; insightful trips to Cuba for US health policymakers, educators and practitioners; Community Partners for Health Equity, a national network of US communities whose leaders have been inspired to innovate for better health, thanks to their MEDICC-organized experiences in Cuba; and by serving as an institutional bridge-builder between US, Cuban and global health institutions and organizations. MEDICC also assists US students and graduates of Havana’s Latin American School of Medicine to return home to practice in provider-shortage areas, and supports US policies that facilitate greater health cooperation with Cuba for the benefit of people in both countries. To achieve our vision of health for all, MEDICC works with a global alliance of people who care about how others in the world live, learn, work, eat, play and receive health care.

Murlean Tucker, Medical Education Cooperation With Cuba, http://www.medicc.org, +1 678-904-8091, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.